Stansberry Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CI
APM
HIIFS
Stansberry Asset Management's XBI Position: Q2 2022 in Review
Stansberry Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2022, closing a stake of 27,305 shares — an estimated $2.45M sold.
Stansberry Asset Management first reported a position in XBI in Q1 2021 and held it in 4 quarters. The position peaked at $10.3M in Q2 2021. 706 funds tracked by Wall St. Rank hold XBI as of Q2 2022.
- Stansberry Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2022 after selling out during the quarter.
- Stansberry Asset Management sold 27,305 State Street SPDR S&P Biotech ETF shares in Q2 2022, an estimated $2.45M.
- Stansberry Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2021 and held it in 4 quarters.
- Stansberry Asset Management's State Street SPDR S&P Biotech ETF position peaked at $10.3M in Q2 2021.
- 706 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2022.
Based on Stansberry Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.